Millions of health care workers are slated to receive the first batch of potentially lifesaving COVID-19 vaccines by the end of this month. But not all of them want to be first in line.
Only one-third of a panel of 13,000 nurses said they would voluntarily take a vaccine; another third said they wouldn’t and the rest said they were unsure, according to a late October survey by the American Nurses Association.
Nina Siegrist, a registered nurse with Hospice of the Piedmont in Charlottesville, Virginia, said she wasn’t at all eager to get a COVID-19 vaccination.
“I actually even hate getting a flu shot, but I’ve had to get one every year since I became a nurse," she said. "Where I stand is that if my medical director says, ‘Listen, all hospice clinicians are going to get vaccinated,’ then I’ll get vaccinated. But I definitely want to read the details on the clinical trials first.”
If nurses and other health care professionals continue to shy away from the shots, some hospitals and clinics say they’ll require employees to get vaccinated if they want to keep their jobs.
But physicians and public health officials interviewed by Stateline predicted that won’t be necessary.
“Some health care professionals may not necessarily want to be the first to roll up their sleeves,” said Dr. Georges Benjamin, executive director of the American Public Health Association. “But eventually, and very quickly, I think they’ll come around.”
Benjamin said that when his time comes to get a shot, he’ll do it, with the caveat that he first wants to read the soon-to-be-released details on the clinical trials.
Dr. Susan Bailey, president of the American Medical Association, said she was confident the nation’s doctors would voluntarily sign up for a shot once they get access to the clinical data.
“As physicians we look to the science and the evidence when we make any type of medical decision," Bailey said. "Physicians need to see that evidence before they can decide. But I’m very confident that once they do see the data, the uptake in the physician population will be very rapid.”
An advisory committee to the federal Centers for Disease Control and Prevention recommended Dec. 1 that the nation’s 21 million health care workers and 3 million long-term care residents receive the first batch of shots – two per person, three weeks apart.
Pfizer, the first manufacturer slated to receive emergency use authorization from the U.S. Food and Drug Administration, has committed to delivering 35 million to 40 million doses by the end of the month under an agreement with the Department of Health and Human Services.
No surprises':53-page FDA report reinforces safety and effectiveness of Pfizer's COVID-19 vaccine candidate
Since that won’t be enough for all health care workers, the CDC’s Advisory Committee on Immunization Practices recommended states determine who gets the vaccines first.
In Alabama, Assistant State Health Officer Dr. Karen Landers said the state is leaving that decision up to hospitals and other medical organizations. Likewise, long-term care and assisted living facilities will determine whether residents, staff or both will be the first to get a shot.
Most other states are taking a similar approach, according to Dr. Marcus Plescia, chief medical officer for the Association of State and Territorial Health Officials.
Alabama also is leaving the task of educating health care professionals on the new vaccines up to medical institutions, Landers said.
On Thursday, Pfizer will release detailed data on its clinical trials in a public FDA hearing. A week later, the FDA will hold a similar hearing on the COVID-19 vaccine developed jointly by Moderna and the National Institutes of Health.
More:Moderna becomes second company to request emergency FDA authorization for COVID-19 vaccine candidate
The same day as those hearings, or shortly thereafter, the FDA is expected to OK the vaccines under what is known as an emergency use authorization. Once authorized, both manufacturers have said they’re ready to begin shipping vaccines.
Though the vaccines signal a potential return to normalcy, a majority of Americans said they would be uncomfortable being among the first to take them, according to a November poll by the Pew Research Center (The Pew Charitable Trusts funds both the Pew Research Center and Stateline).
A substantial minority (39%) said they would not get vaccinated, in part because of the record-shattering speed of the vaccines’ development and the politics surrounding it.
Health care workers are no different, said Dr. William Schaffner, professor of preventive medicine at Vanderbilt University School of Medicine.
“Skepticism about something as new as this vaccine is reasonable whether you’re a health care worker or not," Schaffner said. "It’s a brand-new virus and brand-new vaccines developed with brand-new technologies. What could go wrong?
“We need a lot of information and a lot of reassurance. The facts aren’t enough. It will be very important for health care providers to get the vaccine so they can model the behavior and personalize their stories.
“They can say, ‘I got it. It made my arm hurt for a couple of days, but it was no big deal.’ That will be particularly important for people to hear in local news stories.”
Among the details medical professionals say they’re anxious to see are how many of the 44,000 participants in Pfizer’s clinical trial and 30,000 participants in Moderna’s clinical trials experienced non-life threatening side effects, and whether those symptoms were severe enough to result in missed work.
Both companies say their vaccines are more than 90% effective at preventing COVID-19. And neither has reported extreme adverse effects. A third vaccine, developed by Oxford University in the United Kingdom and produced by drug maker AstraZeneca, also has proven to be 90% effective in clinical trials.
AstraZeneca’s vaccine, which promises to be cheaper and easier to store than Pfizer’s and Moderna’s, is not yet slated for emergency authorization by the FDA.
At the CDC advisory committee meeting last week, public health and medical participants discussed the possibility that COVID-19 vaccinations could cause mild to moderate side effects that would force health care workers to stay home for a day or two.
That could be problematic, with most hospitals already short-staffed and COVID-19 still raging. One solution, the committee suggested, is for hospitals to avoid vaccinating everyone in a single department at the same time.
Immunization specialists in state and local health departments report that only 50% to 70% of health care workers say they’ll take the vaccine, said Claire Hannan, executive director of the Association of Immunization Managers. But Hannan said a vaccination mandate might be counterproductive.
“Health departments feel like their job is to get the vaccines to health care workers and communicate its benefits,” she said. “If you mandate too soon, you can erode trust.”
The nation’s hospitals say they’re likely to wait until the FDA grants full approval to the vaccines to decide whether shots should be mandatory, according to Michelle Hood, executive vice president and chief operating officer of the American Hospital Association.
“That said, if the safety and efficacy information is judged to be as good as the manufacturers have suggested, hospitals and health systems will urge their staff to take the vaccine as an important step to provide additional protection from the serious consequences of COVID-19,” she wrote in an email to Stateline.
For most health care workers, an annual flu shot is compulsory, as are immunizations for measles, mumps, chickenpox and other infectious diseases. And that’s been upheld by courts.
Requiring a COVID-19 vaccination should be no different, legal experts say. But unlike flu shots and other vaccines, the new COVID-19 vaccines aren’t likely to become fully approved by the FDA until March or later. That throws mandates into question, most legal experts say.
In 1905, the U.S. Supreme Court upheld the right of state governments to make smallpox vaccination mandatory to protect the public health, despite common and sometimes severe side effects from the early versions of the vaccine, including skin lesions, muscle aches, fever and fatigue.
James Hodge Jr., a law professor at Arizona State University and director for the Network for Public Health Law’s Western Region Office, said that despite optimism within the medical community about voluntary vaccinations, “I assure you that major health care employers already are thinking about when to mandate the vaccine.
“Nobody in the health care arena will want to be the outlier and have to say we didn’t mandate the vaccine and subsequently had higher COVID infection rates.”
“If history is any guide,” he said, “it will be a very short time before we see mandates.”
Hannan agreed that mandates are likely, but only after the FDA grants full approval of the vaccines. “If you look at the rate of flu shots in health care workers over the last 15 years,” she said, “the dial didn’t really move much until hospitals and employers started requiring them.”